Glomus Jugulare Paraganglioma
- Benign neuroendocrine tumor of neural crest origin arising near the jugular foramen
- Arises from glomus bodies, which function as chemoreceptors
- Located within jugular bulb, cranial nerve IX (CN-IX) tympanic branch and CN-X auricular branch
- Classically spreads through the middle ear in a superior–lateral vector
- May involve CN-VII mastoid segment
- Arterial supply from the ascending pharyngeal artery
- Familial or sporadic
- Associated with multiple endocrine neoplasia type 1 (MEN 1) syndrome, neurofibromatosis type 1 (NF-1), and multiple myocutaneous neuromas
- Patients are at increased risk of thyroid malignancy
- Chief and sustentacular cells within fibromuscular stroma are characteristic microscopic features
- Neurosecretory granules on electron microscopy
- Usually afflicts middle-aged and older adults (40–60 years old)
- Female gender predilection (male/female ratio, 1:4)
- Common presenting signs/symptoms
- Pulsatile tinnitus
- Cranial neuropathy involving CN-IX to CN-XII
- Treatment: surgical resection and radiation; radiosurgery; ±presurgical tumor embolization
- Lobulated solid mass of variable size; often large at presentation
- Hallmark “salt-and-pepper” MRI appearance
- T1 hyperintense “salt” due to subacute hemorrhage; T1 hypointense “pepper” due to arterial flow voids (more commonly seen in larger tumors)
- Adjacent bony changes: permeative-destructive
- Involvement of middle ear common; might invade jugular vein or sigmoid sinus
- Soft tissue mass centered near the jugular foramen
- Avid enhancement on contrast-enhanced CT
- ±Adjacent permeative-destructive bony changes
- T1WI: hyperintense “salt” due to subacute hemorrhage, hypointense “pepper” due to arterial flow voids (more commonly seen in larger tumors)
- T2WI: hyperintense, hypointense flow voids (“pepper”)
- DWI: hyperintense signal that might represent “T2 shinethrough,” hypercellularity, or increased density of axons
- T1WI+C: avid enhancement
- MRV: might show jugular vein and/or sigmoid sinus involvement/occlusion
- Avid fluorodeoxyglucose (FDG) uptake, which can be useful in metastatic evaluation or evaluating treatment response
- MRI without and with intravenous contrast, temporal bone CT to evaluate for adjacent bony changes; consider MRV and PET/CT
For more information, please see the corresponding chapter in Radiopaedia.
Contributor: Rachel Seltman, MD
Christie A, Teasdale E. A comparative review of multidetector CT angiography and MRI in the diagnosis of jugular foramen lesions. Clin Radiol 2010;65:213–217. doi.org/10.1016/j.crad.2009.11.006.
Fayad JN, Keles B, Brackmann DE. Jugular foramen tumors: clinical characteristics and treatment outcomes. Otol Neurotol 2010;31:299–305. doi.org/10.1097/MAO.0b013e3181be6495.
Karaman E, Yilmaz M, Isildak H. Management of jugular paragangliomas in otolaryngology practice. J Craniofac Surg 2010;21:117–120. doi.org/10.1097/SCS.0b013e3181c466ce.
Kemeny AA. Contemporary management of jugular paragangliomas (glomus tumours): microsurgery and radiosurgery. Acta Neurochir (Wien) 2009;151:419–421.
Mafee MF, Raofi B, Kumar A, et al. Glomus faciale, glomus jugulare, glomus tympanicum, glomus vagale, carotid body tumors, and simulating lesions. Role of MR imaging. Radiol Clin North Am 2000;38:1059–1076.
Osborn AG, Salzman KL, Jhaveri MD. Diagnostic Imaging (3rd ed). Elsevier, Philadelphia, PA; 2016.
Ramina R, Maniglia JJ, Fernandes YB, et al. Tumors of the jugular foramen: diagnosis and management. Neurosurgery 2005;57(1 Suppl):59–68; discussion 68. doi.org/10.1227/01.neu.0000163483.44754.47.
Rao AB, Koeller KK, Adair CF, et al. From the archives of the AFIP. Paragangliomas of the head and neck: radiologic-pathologic correlation. Armed Forces Institute of Pathology. Radiographics 1999;19:1605–1632. doi.org/10.1148/radiographics.19.6.g99no251605.
van den Berg R. Imaging and management of head and neck paragangliomas. Eur Radiol 2005;15:1310–1318. doi.org/10.1007/s00330-005-2743-8.
Please login to post a comment.